Quest Diagnostics Net Profit Margin 2010-2024 | DGX

Current and historical net profit margin for Quest Diagnostics (DGX) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Quest Diagnostics net profit margin for the three months ending March 31, 2024 was .
Quest Diagnostics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-03-31 $9.29B $0.84B 9.07%
2023-12-31 $9.25B $0.85B 9.19%
2023-09-30 $9.30B $0.76B 8.16%
2023-06-30 $9.49B $0.79B 8.33%
2023-03-31 $9.60B $0.79B 8.22%
2022-12-31 $9.88B $0.94B 9.53%
2022-09-30 $10.29B $1.23B 11.92%
2022-06-30 $10.58B $1.48B 13.95%
2022-03-31 $10.68B $1.87B 17.55%
2021-12-31 $10.79B $1.99B 18.43%
2021-09-30 $11.05B $2.18B 19.72%
2021-06-30 $11.06B $2.24B 20.27%
2021-03-31 $10.34B $1.80B 17.37%
2020-12-31 $9.44B $1.43B 15.10%
2020-09-30 $8.36B $1.11B 13.22%
2020-06-30 $7.53B $0.75B 9.99%
2020-03-31 $7.66B $0.79B 10.36%
2019-12-31 $7.73B $0.86B 11.11%
2019-09-30 $7.64B $0.73B 9.58%
2019-06-30 $7.57B $0.73B 9.64%
2019-03-31 $7.54B $0.72B 9.59%
2018-12-31 $7.53B $0.74B 9.77%
2018-09-30 $7.56B $0.86B 11.42%
2018-06-30 $7.52B $0.81B 10.78%
2018-03-31 $7.47B $0.79B 10.51%
2017-12-31 $7.40B $0.77B 10.43%
2017-09-30 $7.10B $0.67B 9.44%
2017-06-30 $7.13B $0.70B 9.84%
2017-03-31 $7.17B $0.70B 9.81%
2016-12-31 $7.21B $0.64B 8.90%
2016-09-30 $7.50B $0.68B 9.00%
2016-06-30 $7.50B $0.83B 11.00%
2016-03-31 $7.52B $0.75B 9.95%
2015-12-31 $7.49B $0.71B 9.42%
2015-09-30 $7.53B $0.71B 9.45%
2015-06-30 $7.55B $0.50B 6.60%
2015-03-31 $7.53B $0.51B 6.81%
2014-12-31 $7.44B $0.56B 7.48%
2014-09-30 $7.31B $0.51B 6.96%
2014-06-30 $7.19B $0.79B 10.91%
2014-03-31 $7.11B $0.82B 11.50%
2013-12-31 $7.15B $0.85B 11.88%
2013-09-30 $7.16B $0.76B 10.64%
2013-06-30 $7.20B $0.52B 7.22%
2013-03-31 $7.26B $0.53B 7.34%
2012-12-31 $7.38B $0.56B 7.53%
2012-09-30 $7.37B $0.69B 9.36%
2012-06-30 $7.45B $0.70B 9.38%
2012-03-31 $7.48B $0.68B 9.15%
2011-12-31 $7.39B $0.47B 6.37%
2011-09-30 $7.35B $0.45B 6.08%
2011-06-30 $7.31B $0.47B 6.48%
2011-03-31 $7.28B $0.51B 6.94%
2010-12-31 $7.26B $0.72B 9.93%
2010-09-30 $7.39B $0.74B 9.97%
2010-06-30 $7.43B $0.73B 9.84%
2010-03-31 $7.45B $0.72B 9.71%
2009-12-31 $7.46B $0.73B 9.78%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.353B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.002B 10.28
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Chemed (CHE) United States $8.076B 25.03
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00